{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:19:43Z","timestamp":1767853183785,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ebiom.2021.103760","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T05:47:33Z","timestamp":1639720053000},"page":"103760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Lipoprotein particle alterations due to androgen therapy in individuals with dyskeratosis congenita"],"prefix":"10.1016","volume":"75","author":[{"given":"Mone't B.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Muldoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelvin C.","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelam","family":"Giri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanche P.","family":"Alter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6006-0740","authenticated-orcid":false,"given":"Sharon A.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Shamburek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2473-7800","authenticated-orcid":false,"given":"Payal P.","family":"Khincha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ebiom.2021.103760_bib0001","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/17474086.2019.1662720","article-title":"An update on the biology and management of dyskeratosis congenita and related telomere biology disorders","volume":"12","author":"Niewisch","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.ebiom.2021.103760_bib0002","article-title":"Gastrointestinal Hemorrhage: A Manifestation of the Telomere Biology Disorders","author":"Himes","year":"2020","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103760_bib0003","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/15476286.2015.1094596","article-title":"The molecular genetics of the telomere biology disorders","volume":"13","author":"Bertuch","year":"2016","journal-title":"RNA Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103760_bib0004","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3324\/haematol.2017.178111","article-title":"Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up","volume":"103","author":"Alter","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103760_bib0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1182\/asheducation-2017.1.96","article-title":"Treatment of inherited bone marrow failure syndromes beyond transplantation","volume":"2017","author":"Calado","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103760_bib0006","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/bjh.12748","article-title":"Response to androgen therapy in patients with dyskeratosis congenita","volume":"165","author":"Khincha","year":"2014","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103760_bib0007","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMc1607752","article-title":"Danazol treatment for telomere diseases","volume":"375","author":"Townsley","year":"2016","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103760_bib0008","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/bloodadvances.2018016964","article-title":"Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita","volume":"2","author":"Khincha","year":"2018","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103760_bib0009","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/archinte.1991.00400100013003","article-title":"Atherogenic effects of anabolic steroids on serum lipid levels. A literature review","volume":"151","author":"Glazer","year":"1991","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103760_bib0010","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0149-2918(01)80114-4","article-title":"A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids","volume":"23","author":"Shahidi","year":"2001","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103760_bib0011","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0026-0495(82)90230-X","article-title":"Ballantyne D. High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects","volume":"31","author":"Ballantyne","year":"1982","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103760_bib0012","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11883-004-0050-5","article-title":"Low-density lipoprotein particle number and risk for cardiovascular disease","volume":"6","author":"Cromwell","year":"2004","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ebiom.2021.103760_bib0013","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fphar.2015.00218","article-title":"HDL particle number and size as predictors of cardiovascular disease","volume":"6","author":"Kontush","year":"2015","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103760_bib0014","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy","volume":"26","author":"Jeyarajah","year":"2006","journal-title":"Clin Lab Med"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103760_bib0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.atherosclerosis.2014.09.024","article-title":"The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective","volume":"237","author":"Rankin","year":"2014","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103760_bib0016","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1210\/js.2019-00103","article-title":"Advanced lipoprotein analysis shows atherogenic lipid profile that improves after metreleptin in patients with lipodystrophy","volume":"3","author":"Kinzer","year":"2019","journal-title":"J Endocr Soc"},{"issue":"16-17","key":"10.1016\/j.ebiom.2021.103760_bib0017","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clinbiochem.2014.07.015","article-title":"NMR measurement of LDL particle number using the Vantera Clinical Analyzer","volume":"47","author":"Matyus","year":"2014","journal-title":"Clin Biochem"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103760_bib0018","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.clinbiochem.2014.11.017","article-title":"HDL particle number measured on the Vantera(R), the first clinical NMR analyzer","volume":"48","author":"Matyus","year":"2015","journal-title":"Clin Biochem"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103760_bib0019","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/jama.1996.03540110029028","article-title":"Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women","volume":"276","author":"Gardner","year":"1996","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103760_bib0020","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.ATV.18.7.1046","article-title":"Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease","volume":"18","author":"Freedman","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103760_bib0021","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/met.2016.0145","article-title":"Branched chain amino acids are associated with insulin resistance independent of leptin and adiponectin in subjects with varying degrees of glucose tolerance","volume":"15","author":"Connelly","year":"2017","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.ebiom.2021.103760_bib0022","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.clinbiochem.2018.02.001","article-title":"A novel NMR-based assay to measure circulating concentrations of branched-chain amino acids: Elevation in subjects with type 2 diabetes mellitus and association with carotid intima media thickness","volume":"54","author":"Wolak-Dinsmore","year":"2018","journal-title":"Clin Biochem"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103760_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020511","article-title":"High Plasma Branched-Chain Amino Acids Are Associated with Higher Risk of Post-Transplant Diabetes Mellitus in Renal Transplant Recipients","volume":"9","author":"Oste","year":"2020","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103760_bib0024","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1089\/met.2014.0050","article-title":"Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance","volume":"12","author":"Shalaurova","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103760_bib0025","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1373\/clinchem.2014.232918","article-title":"GlycA: a composite nuclear magnetic resonance biomarker of systemic inflammation","volume":"61","author":"Otvos","year":"2015","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103760_bib0026","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00439-013-1265-8","article-title":"Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita","volume":"132","author":"Ballew","year":"2013","journal-title":"Hum Genet"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103760_bib0027","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1038\/s41598-020-65100-2","article-title":"Serum level of HDL particles are independently associated with long-term prognosis in patients with coronary artery disease: The GENES study","volume":"10","author":"Duparc","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103760_bib0028","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0026-0495(83)90052-5","article-title":"Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy","volume":"32","author":"Haffner","year":"1983","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103760_bib0029","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0026-0495(87)90130-2","article-title":"The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterol","volume":"36","author":"Applebaum-Bowden","year":"1987","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103760_bib0030","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1249\/00005768-198508000-00010","article-title":"Androgens reduce HDL2-cholesterol and increase hepatic triglyceride lipase activity","volume":"17","author":"Kantor","year":"1985","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.ebiom.2021.103760_bib0031","first-page":"35","article-title":"Action of danazol on plasma lipids and lipoprotein metabolism","volume":"159","author":"Packard","year":"1994","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"10.1016\/j.ebiom.2021.103760_bib0032","first-page":"S23","article-title":"Danazol and plasma lipoprotein metabolism","volume":"50 Suppl 1","author":"Shepherd","year":"1995","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103760_bib0033","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0015-0282(16)47957-4","article-title":"Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women","volume":"42","author":"Fahraeus","year":"1984","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103760_bib0034","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/CIRCRESAHA.115.308078","article-title":"Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk","volume":"118","author":"Lawler","year":"2016","journal-title":"Circ Res"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421005545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421005545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:16:05Z","timestamp":1762456565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421005545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":34,"alternative-id":["S2352396421005545"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103760","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein particle alterations due to androgen therapy in individuals with dyskeratosis congenita","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103760"}}